Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 6, 2025

Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2025 financial results on Tuesday, May 13, 2025, after the markets close. Management will conduct …

Cogent Biosciences Reports First Quarter 2025 Financial Results
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million in …

Uplight Secures Leadership in Guidehouse Home Energy Management Providers Category and Unveils New Demand Stack Activation Engine
BOULDER, Colo., May 06, 2025 (GLOBE NEWSWIRE) -- Uplight, a clean energy technology company that unlocks grid capacity by activating customers and their connected devices to generate, shift, and save energy, today announced new distinctions received for …

RTI at AUVSI XPONENTIAL 2025: Accelerating the Future of Autonomy from Concept to Deployment
SUNNYVALE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, will exhibit at AUVSI XPONENTIAL 2025, held May 19-22 at the George R. Brown Convention Center in Houston, TX. At Booth …

BigCommerce Taps Klarna as Global Preferred Partner for Flexible Payment Solutions
AUSTIN, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced that Klarna, the AI-powered payments …

Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other ophthalmic …

Actuate Therapeutics Announces Statistically Significant Topline Results from Global Phase 2 Trial of Elraglusib in First-Line Treatment of Metastatic Pancreatic Cancer
Topline data shows statistically significant improvement in overall survival in elraglusib plus GnP combination arm versus GnP control arm Elraglusib/GnP combination arm demonstrated substantial improvement in median overall survival since the last data …

Krystal Biotech Announces First Quarter 2025 Financial and Operating Results
VYJUVEK approved in Europe for the treatment of DEB patients from birth $88.2 million in 1Q VYJUVEK revenue and $429.4 million since launch in Q3 2023 Second ophthalmic program in clinic - KB801 for the treatment of neurotrophic keratitis Upcoming clinical …

Duos Technologies Group Sets First Quarter 2025 Earnings Call for Thursday, May 15, 2025 at 4:30 PM ET
JACKSONVILLE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) will hold a conference call on Thursday, May 15, 2025 at 4:30 p.m. Eastern time to discuss its financial results for the first …

ZenaTech Expands Ireland Office Offering Drone as a Service (DaaS) Including Precision Agriculture to a European Market Growing at 28.6% Annually
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and …

BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) and Elevated Markers of Cardiac Stress Dr. Amish Raval, Professor of Medicine at the University of …

Lingokids puts Parent Guilt on Trial in First of its Kind Campaign
LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- Today, Lingokids, the #1 interactive app for kids aged 2-8, puts the parenting screen time debate on trial with the launch of its largest U.S. campaign, The Trial by Lingokids. The campaign film highlights the …

Strong Majority of Consumers Express Deep Concern Over Tariff-Driven Price Increases, Optimove Insights Survey Finds
New York, May 06, 2025 (GLOBE NEWSWIRE) -- A strong majority (55%) of U.S. consumers are 'very concerned' about tariffs, stating that price increases are already impacting their budgets, according to new survey results released today by Optimove Insights, …

ParaZero Receives Significant European Order for SafeAir™ M4 Systems from Leading Drone Technology Distributor
Order reflects growing demand for ParaZero’s advanced drone safety solutions across the European commercial and enterprise sectors TEL AVIV, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), …

VAXIL: SHARE CONSOLIDATION
Not for distribution by US newswire or in United States TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities. Vaxil announces …

PeerGame Introduces Seamless Crypto Transactions with WalletConnect Integration
London, UK, May 06, 2025 (GLOBE NEWSWIRE) -- Leading cryptocurrency gaming company PeerGame has announced the launch of its new cashier system - its platform will now be integrated with WalletConnect for seamless, secure, and fast crypto transactions. The …

Caledonia Mining Corporation Plc: Results of Annual General Meeting
ST HELIER, Jersey, May 06, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("the Company") (NYSE American, AIM and VFEX: CMCL) announces the results of its annual general meeting of shareholders (the “AGM”) held at St Helier, Jersey today. The …

Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 13, 2025. Altimmune management …

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
‒ Q1 2025 Net Revenue of $39.1mm; Adjusted EBITDA of $23.6mm ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, NJ., May 06, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on …

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
- Favorable clinical data in PD-(L)1 resistant patients - - Dose expansion enrollment complete with full data expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. …